The PhaSeal System is trusted by and implemented in more than 2000 cancer facilities, infusion centers and private practices across 30+ countries. http://www.carmelpharmausa.com
NIOSH ALERT Publication addresses workers in all healthcare settings and includes this warning:
Working with or near hazardous drugs in health care settings may cause skin rashes, infertility, miscarriage, birth defects and possibly leukemia or other cancers. http://www.cdc.gov/niosh/docs/2004-165/pdfs/2004-165.pdf
The company expanded its safe handling initiatives to the U.S. market with the formation of Carmel Pharma, Inc., which operates a corporate office and distribution facility out of Columbus, OH.
Carmel Pharma was founded in Gothenburg, Sweden in 1994 and has played an active role in the Swedish medical market ever since. Carmel Pharma’s mission is to improve the quality of life of those who prepare, administer and handle waste from hazardous drugs by providing PhaSeal, a unique CSTD with scientifically-documented benefits.
In 1985, the “ASHP Technical Assistance Bulletin on Handling Cytotoxic Drugs in Hospitals” summarized published information on handling hazardous drugs, referred to as cytotoxics, as of July 1984. As more information became available on the types of hazardous agents that may represent a health risk to the occupationally exposed population, and as the handling of such substances became routine in hospitals, community pharmacies, home care settings, clinics, and physicians’ offices, the need to revise the Technical Assistance Bulletin became apparent. www.baxa.com/resources/docs/technicalPapers/ASHPTechBulltn.pdf
Update Sources
